Cibisatamab and FAP-4-1BBL in microsatellite-stable colorectal cancer: a phase 1b trial.
Saved in:
| Title: | Cibisatamab and FAP-4-1BBL in microsatellite-stable colorectal cancer: a phase 1b trial. |
|---|---|
| Authors: | Melero I; Clínica Universidad de Navarra, CIMA and CIBERONC, Pamplona, Spain.; Nuffield Department of Medicine, University of Oxford, Oxford, UK., Tanos T; Roche Pharma Research & Early Development, Roche Innovation Center Basel, Basel, Switzerland., Calvo Aller E; START Madrid-CIOCC, Centro Integral Oncológico Clara Campal, Madrid, Spain., Qvortrup C; Department of Oncology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark., van Dongen M; Netherlands Cancer Institute Antoni van Leeuwenhoek, Amsterdam, The Netherlands., Baraibar I; Vall d'Hebron Hospital Campus and Institute of Oncology (VHIO), CIBERONC, IR-HUVH, Barcelona, Spain., Beom SH; Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Republic of Korea., Thistlethwaite F; The Christie NHS Foundation Trust and University of Manchester, Manchester, UK., Riesco MDC; Medical Oncology Department, Hospital Universitario Doce de Octubre, Madrid, Spain., Garcia MM; Medical Oncology Department, Hospital del Mar Research Institute, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain., Woodcock V; Oxford University Hospitals NHS Foundation Trust, Oxford, UK., Kim TW; Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea., Umana P; Pharma Research & Early Development, Roche Innovation Center Zurich, Zurich, Switzerland., McIntyre C; Roche Pharma Research & Early Development, Roche Innovation Center Welwyn, Welwyn Garden City, UK., Chen L; Roche Pharma Research & Early Development, Roche Innovation Center Basel, Basel, Switzerland., Heichinger C; Roche Pharma Research & Early Development, Roche Innovation Center Basel, Basel, Switzerland., Hinton H; Roche Pharma Research & Early Development, Roche Innovation Center Basel, Basel, Switzerland., Saylan T; Roche Pharma Research & Early Development, Roche Innovation Center Basel, Basel, Switzerland., Davydov II; Computational Sciences Center of Excellence, Roche Innovation Center Basel, Basel, Switzerland., Guarin E; Roche Pharma Research & Early Development, Roche Innovation Center Basel, Basel, Switzerland., Boehnke A; Roche Pharma Research & Early Development, Roche Innovation Center Basel, Basel, Switzerland. axel.boehnke@roche.com., Moreno V; START Madrid-FJD, Hospital Fundación Jiménez Díaz, Madrid, Spain. |
| Source: | Nature medicine [Nat Med] 2026 Apr 20. Date of Electronic Publication: 2026 Apr 20. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Nature Publishing Company Country of Publication: United States NLM ID: 9502015 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1546-170X (Electronic) Linking ISSN: 10788956 NLM ISO Abbreviation: Nat Med Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
